sign

trial

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

In higher dose likely much better than sava .. finally signs of vindication.

Cassava is starting to move again, good sign for us, too.

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Sava has potential and the phase 3 results will show the truth.

business-result

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

drug

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

patient

It can be shown that treatment bringing back independence is less costly than the nursing homes and medical staff.

$AVXL This may show why Anavex is definitely on the right path by using patients personal genetics to determine dosage.

Many claim him to be selfish and unconcerned with others, I see a different Missling, with humility and a deep concern for patients who are suffering.

Half the patients improved over baseline over 1 year.

Blarcamesine’s Phase III clinical trials show similar levels of significant improvement in communication and interaction, as patients had statistically significant improvement in the RSBQ primary endpoint of 72.2% compared to 38.5% on placebo. .

And better still for just those 85% carrying the normal SigmaR1 gene as well as for APOE2 and 3 patients.

new clinical trial results show great promise for treating early Alzheimer’s, giving renewed hope for effective treatments.

Anavex has over 760 patients that have taken it without any significant issues. .

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

ALL signs pointing to absolute success yet this clueless PoS will continue to dick around like it doesn&#39;t know it&#39;s ass from a hole in the ground.

The observant and aware paid attention to the sign on the door that said we have a few things to do to give you the best experience possible--opening soon.

$SAVA It’s a great sign when you Shorts are hanging out here early in the morning.

$SAVA random bears showing spreading FUD, good sign

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

Simufilam reduced dementia-related behavior at 9 months on the Neuropsychiatric Inventory (NPI), a clinical tool widely used to measure changes in dementia-related behavior.

The open label study is a true gift which gives us insight on both health and benefit issues and the med looks great on both counts.

$SAVA September 3rd 2021 Remi  Barbier said, &quot;I truly believe Cassava Sciences is one clinical program away from greatness.

$SAVA Per press release dec 6 2022, Remi stated administration of drug for OL study completed and he is &quot;THRILLED&quot; with the clinical development, or what he see to this date.

$SAVA , VERA announced positive phase 2b results meeting primary end point.

My prediction:
Phase 2 Unbelievable results
FDA fast track
Phase 3 - go ahead
Patients receive sava 
Market cap 40 B by 2024 
Rising to 200 Billion by 2026
Game changer - the only drug in the world to help patients

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Baudax Bio Inc

crash

$BXRX This is like a bloody car crash - I cannot look away.

flow

Money flow now &quot;extreme bearish.&quot;

management

BXRX management and BOD are the definition of FAILURE!!

$BXRX Watching all the new bulls here compared to a month ago, some of you will end up bag holding this for a long time.. this company has some of the most selfish management in the entire market.

This can only be due to fraudulent practices on the part of Baudax Bio management, such as misrepresenting the market potential of Anjeso, lying about the CEO&#39;s credentials, colluding with short sellers, etc.

i’ve watched it for years.. nothing good ever happens with management

Stay far, far away from this toxic stock, company and management.

but that this  company is allowed to continue to serve as an ATM for management, while fleecing investors, is an absolute travesty.

BXRX management should be in jail for what they did to this company.

Company has no viable products, no revenue, incompetent, self-dealing management, multiple dilutions and reverse splits.

split

Look at all the reverse splits in this turd.

$BXRX fucking turds, two splits in one year, Good lord.

$BXRX  😂😂 and yet another split on the way,  what a horrific stock.

A 1 for 40 reverse stock split and an immediate dilution/stock offering……..in other words………a savage ass pounding without even a cigarette break.

stop

but this thang don’t stop tumbling down the mountain

$BXRX ok,  another stop loss raid, its a bullish sign.

By utilizing a specialized database, this study is ensuring the utmost safety and efficacy of the medication.

$NRBO check out all of the trials they have going on and backed by DONG A-ST this is the making of a MEGA RUNNER.

Successful phase 2 which will be final approved April 2023 .

3.67 cash per share and $20+ PT&#39;s. Not to mention, consistency with positive studies and data.

I can only imagine how useful it will be clinical setting, much like a Toradol Injection is used.

$SNAP $META $GOOGL $PINS gonna go up
$BXRX is just getting started imo huge phase 2 trial and great fundamentals

$AFRM $UPST $SOFI $DLO good fintech companies 
$BXRX holy shiiii amazing news with starting their trials and great fundamentals

news

$ENSC big news coming in days ahead,  very cheap.

Mid day top percent stock gainers on news and/or vol.

$INPX $BIAF $GROM $BXRX $COSM  very strong holding  above 1.90 that great news for tomorrow

We are the only low float good news stock today.

Analysts have set a price target of $3 for ENSC&#39;s stock, making it a strong buy for those looking to invest in the future of the industry🔥🚀 
 
Also following: 
$THMO $HUBC $TRKA $BXRX

$REVB More and More buys from all over the market are entering here now.

$INPX volume swelling on buys coming in locking it up
$BXRX go bulls!

🚨   $SPRC This could be the greatest buy in small caps right now or at least one of them.

Prty more up, cosm $4 buy spot,  Htgm filling premarket, slapping in 🔥

hold

$BXRX Long term hold for me PT 10 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

.It will move on thin air 
$sidu is a nice hold 
$boxd nice volume.

$BXRX Once again bulls prove they can&#39;t hold shit

$BXRX as long as it holds the VWAP it is still bullish.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 24, 2023

Jan, 17, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Mar, 15, 2023

Feb, 9, 2023

Discover Your Wealth Potential with Stock Advisor

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Jan, 24, 2023

Dec, 22, 2022

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 24, 2023

Jan, 17, 2023

Jan, 12, 2023

Jan, 11, 2023

Jan, 10, 2023

Jan, 5, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Mar, 15, 2023

Feb, 9, 2023

Jan, 9, 2023

Dec, 30, 2022

Dec, 30, 2022

Dec, 14, 2022

Dec, 6, 2022

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Jan, 24, 2023

Dec, 22, 2022

Dec, 9, 2022

Dec, 9, 2022